As someone said, I can beat a dead horse, because the horse
As someone said, I can beat a dead horse, because the horse doesn't care. In addition to all his scientific contributions, BP's pointed wit is why many miss his being with the company. Of course, Dr. Jay isn't bad either.
That being said, Cytodyn appears to be on its way back. Momentum is slowly building, and results will always carry the day. As always, we'll be holding our collective breath until the CC on Tuesday. We can only hope that NP will provide some meaningful input as to EUA approval, non-toxic funding, including potential sales, and uplisting to NAZ. This is what the market wants to hear. Anything short of these and disappointment will set in again.
I do believe NP gets it. He can't fabricate PR's, but he can recognize the impact and timing of his statements on the market, up or down. He is not my favorite for the face and voice of the company, but I truly do like him. I believe he is a driven and honorable CEO. However, he still has to deliver.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
NVIDIA's Conference Call for Third-Quarter Financial Results NVIDIA is preparing to host a conference call where the company's financial results for the third quarter will be addressed. This call is scheduled for Wednesday, November 20, at 2 p.m. PT, allowing both analysts and investors an opportunity to understand the company's performance in a detailed manner. Live...
Continue Reading
Endeavour Mining Conducts Share Buyback Endeavour Mining plc, a leading gold producer, has recently undertaken a strategic initiative by purchasing its own shares in the market. This move signifies a strong commitment to enhancing shareholder value and reflects the company’s robust financial posture. Overview of the Shares Purchased The company acquired a total of...
Continue Reading
Unveiling the Train of Glamour Experience Journey Beyond the Ordinary: The Train is The Destination Welcome aboard the Train of Glamour, a luxurious travel experience that redefines railway tourism in China. With an expanded route schedule in 2025, the Train of Glamour offers travelers a unique opportunity to explore breathtaking Chinese landscapes and diverse cultures....
Continue Reading
Critical Information for Flywire Corporation Investors If you have invested in Flywire Corporation (NASDAQ: FLYW) and experienced financial losses, it’s essential to pay attention to the upcoming deadline for a class action lawsuit. The Law Offices of Frank R. Cruz is reaching out to inform you of your rights regarding your investment losses and the ongoing litigation...
Continue Reading
Innovating in Biotechnology: A Bright Future Ahead The biotechnology sector is witnessing a remarkable transformation, largely fueled by advancements in artificial intelligence (AI). Companies are now leveraging machine learning to effectively identify drug targets, enhance molecular structures, and make accurate predictions regarding clinical trial outcomes. This...
Continue Reading